Patents by Inventor Michelle Dipp

Michelle Dipp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
    Publication number: 20070149466
    Abstract: Provided herein are methods and compositions for treating or preventing metabolic disorders, such as obesity and diabetes. Methods may comprise modulating the activity or level of a sirtuin, such as SIRT1 or Sir2. Exemplary methods comprise contacting a cell with a sirtuin activating compound, such as a flavone, stilbene, flavanone, isoflavone, catechin, chalcone, tannin or anthocyanidin, or an inhibitory compound, such as nicotinamide.
    Type: Application
    Filed: March 16, 2006
    Publication date: June 28, 2007
    Inventors: Michael Milburn, Jill Milne, Johan Auwerx, Carmen Argmann, Marie Lagouge, Michelle Dipp
  • Treatment of eye disorders with sirtuin modulators
    Publication number: 20070014833
    Abstract: Sirtuin modulators, particularly sirtuin activators, are useful in treating vision impairment. In general, the sirtuin modulators inhibit the progression of vision impairment resulting from various eye disorders. The invention also includes pharmaceutically acceptable formulations of sirtuin modulators, particular ophthalmically acceptable formulations.
    Type: Application
    Filed: October 28, 2005
    Publication date: January 18, 2007
    Applicant: Sirtris Pharmaceuticals, Inc.
    Inventors: Michael Milburn, Christoph Westphal, Michelle Dipp
  • Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
    Publication number: 20060276393
    Abstract: Provided herein are methods and compositions for treating or preventing neurodegenerative disorders or blood coagulation disorders. Methods may comprise modulating the activity or level of a sirtuin, such as SIRT1 or Sir2. Exemplary methods comprise contacting a cell with a sirtuin activating compound, such as a flavone, stilbene, flavanone, isoflavone, catechin, chalcone, tannin or anthocyanidin; or an inhibitory compound, such as nicotinamide.
    Type: Application
    Filed: January 13, 2006
    Publication date: December 7, 2006
    Applicant: Sirtris Pharmaceuticals, Inc.
    Inventors: Michael Milburn, Jill Milne, Christoph Westphal, Karl Normington, Jennifer Fujii, Michelle Dipp, Peter Elliott